NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $301,404 | +0.9% | 2,959 | 0.0% | 0.03% | +3.4% |
| Q2 2023 | $298,593 | +9.7% | 2,959 | 0.0% | 0.03% | +3.6% |
| Q1 2023 | $272,228 | -65.8% | 2,959 | -66.3% | 0.03% | -69.2% |
| Q4 2022 | $797,066 | +19.3% | 8,786 | 0.0% | 0.09% | +8.3% |
| Q3 2022 | $668,000 | -9.9% | 8,786 | +0.3% | 0.08% | -5.6% |
| Q2 2022 | $741,000 | -3.6% | 8,762 | 0.0% | 0.09% | +12.7% |
| Q1 2022 | $769,000 | -0.5% | 8,762 | -0.9% | 0.08% | +2.6% |
| Q4 2021 | $773,000 | -2.9% | 8,839 | -9.2% | 0.08% | -12.5% |
| Q3 2021 | $796,000 | -11.7% | 9,736 | -1.4% | 0.09% | -12.9% |
| Q2 2021 | $901,000 | +6.8% | 9,879 | 0.0% | 0.10% | -4.7% |
| Q1 2021 | $844,000 | -8.2% | 9,879 | +1.6% | 0.11% | -15.9% |
| Q4 2020 | $919,000 | +9.1% | 9,727 | +0.4% | 0.13% | -4.5% |
| Q3 2020 | $842,000 | -0.6% | 9,687 | -0.1% | 0.13% | -8.3% |
| Q2 2020 | $847,000 | +3.8% | 9,695 | -2.0% | 0.14% | -16.8% |
| Q1 2020 | $816,000 | -5.2% | 9,897 | +8.9% | 0.17% | +5.5% |
| Q4 2019 | $861,000 | +9.7% | 9,090 | +0.6% | 0.16% | -3.0% |
| Q3 2019 | $785,000 | -3.2% | 9,032 | +1.6% | 0.17% | -7.7% |
| Q2 2019 | $811,000 | -1.7% | 8,887 | +3.6% | 0.18% | -6.6% |
| Q1 2019 | $825,000 | +18.2% | 8,580 | +5.5% | 0.20% | 0.0% |
| Q4 2018 | $698,000 | +18.9% | 8,130 | +19.3% | 0.20% | +35.2% |
| Q3 2018 | $587,000 | +18.3% | 6,815 | +3.8% | 0.14% | +11.5% |
| Q2 2018 | $496,000 | +4.2% | 6,565 | +11.5% | 0.13% | -3.0% |
| Q1 2018 | $476,000 | -31.3% | 5,890 | -28.6% | 0.13% | -25.1% |
| Q4 2017 | $693,000 | -43.7% | 8,255 | -43.2% | 0.18% | +0.6% |
| Q3 2017 | $1,230,000 | +102.0% | 14,530 | +99.2% | 0.18% | 0.0% |
| Q2 2017 | $609,000 | +12.4% | 7,295 | 0.0% | 0.18% | +6.0% |
| Q1 2017 | $542,000 | +2.1% | 7,295 | 0.0% | 0.17% | -1.2% |
| Q4 2016 | $531,000 | -82.7% | 7,295 | -77.7% | 0.17% | -87.7% |
| Q3 2014 | $3,078,000 | +3.0% | 32,698 | -0.9% | 1.38% | +14.6% |
| Q2 2014 | $2,987,000 | +1.8% | 32,998 | -4.4% | 1.21% | -15.2% |
| Q1 2014 | $2,935,000 | +5.5% | 34,522 | -0.3% | 1.42% | +11.7% |
| Q4 2013 | $2,783,000 | +1.8% | 34,622 | -2.8% | 1.28% | -10.1% |
| Q3 2013 | $2,733,000 | +9.4% | 35,622 | +0.8% | 1.42% | -9.5% |
| Q2 2013 | $2,499,000 | – | 35,347 | – | 1.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |